e-learning
resources
Stockholm 2007
Monday 17.09.2007
Clinical aspects of pulmonary arterial hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation
B. Sztrymf, A. Yaïci, F. Coulet, B. Girerd, O. Sitbon, X. Jaïs, G. Simonneau, F. Soubrier, M. Humbert (Clamart, Paris, France)
Source:
Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Session:
Clinical aspects of pulmonary arterial hypertension
Session type:
Oral Presentation
Number:
1594
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Sztrymf, A. Yaïci, F. Coulet, B. Girerd, O. Sitbon, X. Jaïs, G. Simonneau, F. Soubrier, M. Humbert (Clamart, Paris, France). Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation. Eur Respir J 2007; 30: Suppl. 51, 1594
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Asbestosis
Related content which might interest you:
Clinical presentation, hemodynamical characteristics and survival of patients with pulmonary arterial hypertension carrying or not a
BMPR2
mutation
Source: Eur Respir J 2005; 26: Suppl. 49, 352s
Year: 2005
Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Screening of pulmonary arterial hypertension in BMPR2 mutation carriers
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Phenotype and outcome of pulmonary arterial hypertension patients carrying a
TBX4
mutation
Source: Eur Respir J, 55 (5) 1902340; 10.1183/13993003.02340-2019
Year: 2020
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation
Source: Eur Respir J 2012; 39: 1534-1535
Year: 2012
Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
Source: Eur Respir Rev 2014; 23: 147-149
Year: 2014
Familial pulmonary arterial hypertension by
KDR
heterozygous loss of function
Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019
Year: 2020
Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
Source: Eur Respir J 2012; 39: 597-603
Year: 2012
Absence of influence of gender on clinical phenotypes in BMPR2 mutation carriers with pulmonary arterial hypertension from the French registry
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010
BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1668-1681
Year: 2016
Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
Source: Eur Respir J 2004; 24: 371-374
Year: 2004
Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 1195-1198
Year: 2014
First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Clinical phenotypes and outcomes of pulmonary veno-occlusive disease in carriers of bi-allelic EIF2AK4 mutations
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations
Source: Eur Respir J 2012; 40: 1287-1289
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept